Hospital Medicine

Experts from the Violence Intervention Advocacy Program of the Boston Medical Center share insight from their research examining the spike of violence observed early in the COVID-19 pandemic.

Patients with diarrhea did have longer hospital stays than patients without diarrhea.

The University of Colorado expert joins for a 5-part interview on making sense of the boom of new agents and care strategies.

The Yale Associate Chief of Cardiovascular Medicine discusses improved use of available drug classes, as well as the potential approval for omecamtiv mecarbil.

From a couple of novel heart failure treatments to a promising dual receptor agonist, here's a rundown of expected pipeline news this year in heart disease.

The absolute survival rate observed for US patients with IHCA and COVID-19 was 11.9%.

The president of Make-A-Wish New Jersey speaks about the impact of granting a wish to a child living with a rare disease.

The CDC has estimated at least 2.4 million flu illnesses, 23,000 hospitalizations, and 1,400 deaths from flu so far this season.

More than 40% of community-acquired and 70% of hospital-acquired influenza inpatients experienced intrahospital bed transfers during their active infection period.

The 2 companies are expected to seek regulatory authorization for the COVID-19 vaccine.

The estimated mean change in body weight from baseline to week 68 was -13.2% in the semaglutide 2.4 mg group versus -2.1% in the placebo group.

With the field already booming with capability, a Penn Medicine expert discusses her team's research into finding the right tools for the right patients and clinicians.

An executive with Seqirus discusses the company's work to address age-related flu severity risks.

A new study suggests even the phrasing of telemedicine notifications may make a difference in vaccine uptake.

Retrospective cohort data show older veteran patients have generally a 20% reduced risk of 30-day mortality when treated for emergent care at a VA hospital.

A 3-part series on the manifestations of physician burnout, how COVID-19 changed its scope and revealed systemic fractures, and finally, the path towards resolution and reformation.

Intravenous tramadol, developed by Avenue Therapeutics, fails to attain FDA approval as treatment for acute pain in adults.

An Israel cohort analysis suggests a "hybrid" of natural and vaccine-induced immunity is associated with the rare likelihood of SARS-CoV-2 reinfection.

The new hospital featured 50% private rooms, as well as regular cleaning and other preventative measures for C difficile infections.

Califf previously served as FDA commissioner under the Obama Administration after a 35-year career at Duke University.

A pilot trial suggests telemedicine methods need to be tailored to reach adversely affected populations including Black patients on Medicare or Medicaid.

Sharp candidly discusses the need for new solution ideas to strike while the iron is hot, during this rebuilding stage of the healthcare system.

A Finnish national study suggests hard-to-reach adults may seek a flu shot if provided direct information on its benefits.

Our third and final episode on physician burnout traces the path towards a solution and ultimately, reformation in the system as a whole.

The investigators found 56.7% of nursing home patients and 68.1% had multi-drug resistant organism-positive results at enrollment.